Also trades as: NAMSW (NASDAQ) · $vol 0M
NAMS NASDAQ
NewAmsterdam Pharma Company N.V.
1W: -13.3%
1M: -0.3%
3M: -5.7%
YTD: -4.2%
1Y: +78.6%
3Y: +159.4%
5Y: +242.7%
$35.75
+2.03 (+6.02%)
After Hours: $35.10 (-0.65, -1.82%)
Weekly Expected Move ±10.9%
$28
$32
$35
$39
$43
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$4.2B
52W Range16.785-42.205
Volume1,215,111
Avg Volume1,128,808
Beta0.03
Dividend—
Analyst Ratings
Company Info
CEOMichael Harvey Davidson Facp.
Employees68
SectorHealthcare
IndustryBiotechnology
IPO Date2021-02-09
Websitenewamsterdampharma.com
Gooimeer 2-35
Naarden 1411 DC
NL
Naarden 1411 DC
NL
31 35 206 2971
About NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases. Its lead investigational candidate, obicetrapib, is a novel, selective inhibitor that targets the Cholesteryl Ester Transfer Protein (CETP), which has been clinically shown to reduce low-density lipoprotein cholesterol (LDL-C) while at the same time substantially increase high-density lipoprotein cholesterol (HDL-C). The company was founded in 2019 and is based in Naarden, the Netherlands.
Latest News
Monster Beverage, Westrock Coffee, Himax Technologies And Other Big Stocks Moving Higher On Friday
NewAmsterdam Pharma Company N.V. (NAMS) Reports Q1 Loss, Tops Revenue Estimates
NewAmsterdam Pharma reports Q1 results
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| LANGE LOUIS G | S-Sale | 44,173 | $30.41 | 2026-03-11 |
| LANGE LOUIS G | S-Sale | 446 | $31.23 | 2026-03-11 |
| LANGE LOUIS G | X-InTheMoney | 44,619 | $11.50 | 2026-03-09 |
| LANGE LOUIS G | X-InTheMoney | 44,619 | $11.50 | 2026-03-09 |
| Kastelein Johannes J | M-Exempt | 101,409 | — | 2026-03-09 |